Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series D pulls in $30mm for Satiety

Executive Summary

Satiety (minimally invasive devices to treat obesity and gastrointestinal conditions) raised $30mm in its Series D financing led by first-time backer Skyline Ventures. Other new investors HLM Venture Partners and Pinnacle Ventures were joined by returning shareholders Venrock Associates, Three Arch Partners, Morgenthaler Ventures, and Thomas Fogarty Engineering.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies